Human Immunodeficiency Virus Type-1 Market: Industry Outlook and Growth Prospects till 2033
The Human Immunodeficiency Virus Type-1 (HIV-1) market includes a range of therapeutic drugs and treatments designed to manage and suppress the replication of HIV-1, the most common strain of the HIV virus. These therapies include antiretroviral drugs (ARVs) such as nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors, integrase inhibitors, and combination therapies aimed at improving the quality of life and prolonging the life expectancy of individuals living with HIV-1.